[Pharmacological properties and clinical efficacy of entecavir monohydrate (Baraclude Tablet 0.5 mg), an anti-HBV drug].
Amano
Manabu
M
manabu.amano@bms.com
Goto
Arata
A
D000328:Adult; D000818:Animals; D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity; D002986:Clinical Trials as Topic; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral; D004195:Disease Models, Animal; D006147:Guanine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D006509:Hepatitis B / Q000188:drug therapy* / Q000235:genetics; D006515:Hepatitis B virus / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008297:Male; D019384:Nucleic Acid Synthesis Inhibitors; D010766:Phosphorylation; D013607:Tablets; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D004279:DNA, Viral; D019384:Nucleic Acid Synthesis Inhibitors; D013607:Tablets; C413685:entecavir; D006147:Guanine